903522-46-3

Upstream product

• 903522-43-0 (1aS,2aR,5S,6aR,7aS)-2a-((Z)-Heptadec-10-enyl)-5-methyl-7a-triethylsilanyloxy-hexahydro-1,3,6-trioxa-cyclopropa[b]naphthalen-4-one 
• 903522-44-1 (3S,4aR,7S,8aR)-7-(tert-Butyl-dimethyl-silanyloxy)-8a-((Z)-heptadec-10-enyl)-3-methyl-tetrahydro-benzo[1,4]dioxine-2,6-dione 
• 903522-54-3 (2S,4R,5R)-2-(tert-Butyl-dimethyl-silanyloxy)-4-((Z)-heptadec-10-enyl)-4,5-dihydroxy-cyclohexanone 
• 903522-51-0 (3S,4aS,8aR)-5-Bromo-8a-((Z)-heptadec-10-enyl)-3-methyl-4a,8a-dihydro-5H-benzo[1,4]dioxine-2,6-dione 
• 903522-42-9 (3S,4aR,8aR)-8a-((Z)-Heptadec-10-enyl)-3-methyl-4a,8a-dihydro-5H-benzo[1,4]dioxine-2,6-dione 

Downstream Products

• 903522-36-1 (4R,6R)-dihydroxy-4-(10(Z)-heptadecenyl)-2-cyclohexenone 

Relevant academic research and scientific papers

General synthesis for chiral 4-alkyl-4-hydroxycyclohexenones

Some selective transformations of resorcinol-derived cyclohexadienone are reported. Efforts led to a structure reported to display anticancer properties. On the basis of the results, the structures for natural products reported to contain a 4,6-dihydroxy-4-alkyl-cyclohexenone nucleus are corrected.